Investment

CVS voluntarily pulling decongestants from shelves that contain ineffective ingredient

1 Mins read

CVS Health Corp.
CVS,
-1.47%
is pulling decongestants off their shelves that contain an ingredient an Food and Drug Administration advisory committee determined did not work, according to a Thursday report from the Wall Street Journal. Used as a key ingredient in decongestants for nearly a century, FDA advisors in September determined that phenylephrine did not improve congestion. While the FDA has not made a decision on the ingredient, CVS said it is voluntarily taking products containing it off their shelves. CVS shares were last up 0.1% in recent activity.

Read the full article here

Related posts
Investment

Is Magnificent 7 Momentum Setting Investors Up for Disappointment?

1 Mins read
The Magnificent Seven stocks have experienced remarkable earnings and free-cash-flow growth in recent years, all while developing the next generation of technological…
Investment

This fund manager stopped worrying about economics. Now he is outperforming the stock market.

4 Mins read
A change in strategy has helped transform the GoodHaven Fund from a long-term underperformer into an outperformer since the end of 2019….
Investment

After 34 years, Japan’s Nikkei 225 completes a roundtrip

2 Mins read
The Nikkei 225 — an oddly constructed index covering the top 225 Japanese companies — is back at levels not reached since…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *